Apr 04, 2018

Fagron Strengthens Strategic Position in USA Through Highly Complementary Acquisition of Humco

Fagron announces today the acquisition of Humco, a leading developer, manufacturer and supplier of patented delivery vehicles and branded pharmaceutical products to over 45,000 pharmacies in the USA. The acquisition price for Humco amounts to US$ 47.5 million (approximately € 38.6 million) in cash, with the potential for a performance linked earn-out of up to US$ 22.5 million (approximately € 18.3 million) in cash over a two-year period. The total consideration for the acquisition of Humco is thus capped at US$ 70.0 million (approximately € 56.9 million). The transaction includes all technologies, scientific data, patents and trademarks, as well as the production facility of Humco in Texas (USA).

Humco, founded in 1872 as Hutchison Medicine Company, realized a turnover of approximately US$ 32 million (approximately € 26 million) and an EBITDA-margin in line with that of the activities of Fagron North-America in 2017. The company is focused on developing, manufacturing and commercializing innovative patented delivery vehicles (including topical and transdermal creams, syrups and suspensions) and branded pharmaceutical products that are cash-paid by the customer (not reimbursed). In 2016, Humco added a limited portfolio of active pharmaceutical ingredients to its product offer. Humco serves over 45,000 pharmacies in the USA, mainly indirectly through pharmacy chains and wholesalers. Humco is located in Austin (Texas, USA) and has a state-of-the-art FDA registered, cGMP compliant production facility in Texarkana (Texas, USA). All 140 employees from Humco join Fagron, bringing expertise to innovate and serve an expanded customer base worldwide.

"I am pleased to welcome Humco to Fagron Group. Their high-quality portfolio of branded pharmaceutical products and widely used patented delivery vehicles that are supplied to a broad customer base of pharmacy chains and wholesalers in the USA is highly complementary to our extensive range of active pharmaceutical ingredients. Humco is an excellent strategic fit for Fagron. By combining the two companies, we create a strong competitive company with significant scale, strengthening our market position in the USA. Our global footprint and leading market positions in Europe and South-America will enable us to successfully launch and grow the innovative branded pharmaceutical products and delivery vehicles of Humco outside the USA. We look forward to welcome the Humco employees to the Fagron family," said Rafael Padilla, Fagron's CEO.

Following the transaction, Gregory Pulido, Humco's Chairman and CEO, will transition to the role of Executive Chairman while Andrew Pulido, Humco's current President, Global Pharmaceuticals, will assume the sole role of President at Humco.

"We are delighted and proud to become part of the Fagron Group. Being part of a large global organization and a world leader in pharmaceutical compounding creates a more capable and dynamic company for our customers and employees. We complement each other, selling in adjacent markets with very little customer overlap, enabling a significant number of growth opportunities. While we introduce our successful and unique patented delivery vehicles and branded pharmaceutical products internationally, our customers can benefit from the excellent range of more than 1,600 high quality active pharmaceutical ingredients of Fagron," said Gregory Pulido.

Andrew Pulido said, "I am honored to become Humco's President at such an exciting time. The joint activities of Fagron and Humco are extremely well positioned to capitalize on growth opportunities in the USA and around the world. I am confident that our expertise, creativity and dedication will enable us to offer increased value to our customers, suppliers and employees as well as to further extend Fagron's leadership in the market for personalized medication."

Market Buzz

Apr 17, 2018 25% OFF Pharmacy Software License Fee
Apr 04, 2018 TCGRx Announces the Acquisition Of ARxIUM’S Panasonic Fastpak Exp and Fastpak ...
Apr 04, 2018 Fagron Strengthens Strategic Position in USA Through Highly Complementary Acquis...
Mar 30, 2018 KeyCentrix appoints Luis Rodriguez as President
Mar 27, 2018 iMedicare Rebrands to Amplicare, a Decision-Automation Platform that Enables Hea...
Mar 27, 2018 Mercyhealth Adopts Omnicell’s XR2 Automated Central Pharmacy System to Enhance...
Mar 26, 2018 Washington State University Wins 8th Annual Student Pharmacist Compounding Compe...
Mar 26, 2018 H+H SYSTEM, Inc. USA Appoints Marketing Manager
Mar 22, 2018 CVS Health Appoints Derica W. Rice as President of CVS Caremark
Mar 19, 2018 MEDISCA Signs Out-Licensing Agreement with Torrey Hills Technologies for its Pro...
Mar 16, 2018 QS/1® Achieves Level 2 Capability for the Pharmacist Electronic Care Plan
Mar 14, 2018 SuiteRx a Pharmacy Owner's Dream
Mar 13, 2018 Introducing Mission Critical Delivery Solutions as a Thought Leader in Long Term...
Mar 09, 2018 Smith Drug Company Receives the 2018 Distribution Management Award for Cloud-Bas...
Mar 09, 2018 Albertsons Companies Earns URAC Accreditation in Specialty Pharmacy
Mar 06, 2018 Introducing AmerisourceBergen as a Thought Leader & Innovator in Pharmacy: Impro...
Mar 06, 2018 MHA Members WIN BIG with SuiteRx
Mar 02, 2018 Letco Medical, L.L.C. Announces Launch Of Innovative Education Value Program For...
Feb 26, 2018 J M Smith Corporation Announces Leadership Team Changes
Feb 26, 2018 Worz Named New ASCP Executive Director and CEO
Feb 16, 2018 RxSafe Launches Revolutionary Adherence Packaging Automation for Retail Pharmaci...
Feb 15, 2018 Craneware: Significant Contract Wins
Feb 13, 2018 Pomona Valley Hospital Medical Center Adopting In-House IV Compounding with Omni...
Feb 12, 2018 Verity Solutions tops 340B Management Systems Category in 2018 Best in KLAS repo...
Feb 12, 2018 ARxIUM’s RIVA Named Top IV Robot by KLAS for Fifth Consecutive Year
Feb 07, 2018 Multiple Hospitals Adopt Omnicell’s XR2 Automated Central Pharmacy System to E...
Feb 06, 2018 PharmaLink Educates Pharmacy Industry as a Thought Leader in Pharmaceutical Retu...
Feb 05, 2018 Fagron, Inc. Extends Pharmaceutical Ingredient Supply Chain To American Pharmace...
Jan 31, 2018 Letco Med, L.L.C. Announces Partnership with ARL Bio Pharma to Launch Quality Sa...
Jan 29, 2018 LP3 Network Celebrates Grand Opening of New State-of-the-Art Learning Center

RXinsider Product Overview Videos